Anti‐TNF‐α therapy alters the gut microbiota in proteoglycan‐induced ankylosing spondylitis in mice

Ankylosing spondylitis is a chronic, progressive disease, and its treatment is relevant to the gut microbiota. Anti‐tumor necrosis factor‐alpha (anti‐TNF‐α) therapy alters the gut microbiota in many diseases, including inflammatory bowel disease. However, little is known about the effect of TNF‐α bl...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Microbiologyopen
Main Authors: Liu, Bin, Yang, Lianjun, Cui, Zhifei, Zheng, Junchi, Huang, Jincheng, Zhao, Qinghao, Su, Zhihai, Wang, Min, Zhang, Weicong, Liu, Jinshi, Wang, Tingxuan, Li, Qingchu, Lu, Hai
Formato: Artigo
Idioma:Inglês
Publicado: John Wiley and Sons Inc. 2019
Assuntos:
Original Articles
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6925169/
https://ncbi.nlm.nih.gov/pubmed/31556231
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mbo3.927
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares